Triglyceride–glucose related index and its association with coronary heart disease risk in patients with metabolic dysfunction-associated steatotic liver disease: a retrospective analysis based on type 2 diabetes mellitus - Top-Institutions - MDSpire

Triglyceride–glucose related index and its association with coronary heart disease risk in patients with metabolic dysfunction-associated steatotic liver disease: a retrospective analysis based on type 2 diabetes mellitus

  • By

  • Xuying Zhao

  • Yang Hong

  • Saiyan Bian

  • Hui Jiao

  • Xingjian Zhong

  • Wenkai Ni

  • June 16, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    NYU Langone Hospitals
    NYU Langone Hospitals

    New York, NY

    Key Differentiators

    • Cardiology
    • Diabetes
    • Hepatology

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Vascular Surgery

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Endocrinology

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Endocrinology

  • #5

    Cleveland Clinic – Heart, Vascular & Thoracic Institute
    Cleveland Clinic – Heart, Vascular & Thoracic Institute

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Vascular Surgery

Original Source(s)

Triglyceride–glucose related index and its association with coronary heart disease risk in patients with metabolic dysfunction-associated steatotic liver disease: a retrospective analysis based on type 2 diabetes mellitus

  • by Xuying Zhao, Yang Hong, Saiyan Bian, Hui Jiao, Xingjian Zhong, Wenkai Ni

  • June 16, 2026

Related Content

Experts question diet guidelines' higher protein-intake advice

Mortality and Causes of Death After Metabolic Bariatric Surgery in Older Patients

Chronotropic incompetency during stress echocardiography: a new paradigm for mortality and cardiac event prediction?